Tissue engineering bone based on placenta source filling dry cell and production thereof
A stromal stem cell and tissue engineering technology, which is applied in the field of tissue engineered bone based on placenta-derived mesenchymal stem cells and its manufacture, can solve the problems of lack of detailed methods for large-scale separation, purification and expansion of placenta-derived mesenchymal stem cells. , to achieve the effect of convenient clinical application, no immune rejection, and large harvest
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0020] Example 1 The acquisition of human placenta-derived mesenchymal stem cells
[0021] Immediately after delivery, the placenta is placed in a sterile tray or container, injected with balanced salt solution containing anticoagulants and antibiotics via the umbilical artery, exsanguinated, and perfused. The anticoagulant can be 1~100u / mL heparin, and the antibiotic can be penicillin and streptomycin. Collect the perfusate and centrifuge to obtain cell components; or aseptically cut the placental leaflets after the initial perfusion, digest the placental tissue with trypsin or collagenase to obtain a cell suspension, and then pass the cell suspension through a cell sieve to remove tissue debris and blood cells, The obtained cells were resuspended, centrifuged at 500g for 30 minutes with percoll with a density of 1.073g / mL, harvested the interfacial cell layer, washed with PBS and inoculated into culture bottles or culture plates, or directly used for other purposes. It is a...
Embodiment 2
[0022] Example 2 A method for manufacturing tissue-engineered bone based on placenta-derived mesenchymal stem cells
[0023] Freshly isolated or cryopreserved human placenta-derived mesenchymal stem cells were prepared into 1.5-2×10 7 / ml of cell suspension, inoculated onto the scaffold material, trying to make the cells evenly distributed. In a preferred solution, the scaffold material adopts cylindrical β-TCP. The β-TCP porous bioceramic material can be produced by the patented method and process of Shanghai Biolu Company, and the material is passed through 60gray 60 Co irradiated and sterilized for tissue engineered bone construction. In a preferred solution, its microstructure is: pore diameter -100-300 μm, porosity -52%, inter-pore connection diameter -30-100 μm. After standing still for 6 hours, the complexes were transferred into RCCS (rotary bioreactor, Synthecom Company), and cultured in DMEM containing 10% FCS for 48 hours at a rotation speed of 30 rpm. The cultur...
PUM
Property | Measurement | Unit |
---|---|---|
pore size | aaaaa | aaaaa |
porosity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com